Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia
Familial hypercholesterolemia (FH) is the most common monogenic metabolic disorder characterized by considerably elevated low-density lipoprotein cholesterol (LDL-C) levels leading to enhanced atherogenesis, early cardiovascular disease (CVD), and premature death. However, the wide phenotypic hetero...
Main Authors: | Eszter Berta, Noémi Zsíros, Miklós Bodor, István Balogh, Hajnalka Lőrincz, György Paragh, Mariann Harangi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/13/7/1158 |
Similar Items
-
Decreased Serum Stromal Cell-Derived Factor-1 in Patients with Familial Hypercholesterolemia and Its Strong Correlation with Lipoprotein Subfractions
by: Lilla Juhász, et al.
Published: (2023-10-01) -
Determination of Serum Progranulin in Patients with Untreated Familial Hypercholesterolemia
by: Bíborka Nádró, et al.
Published: (2022-03-01) -
Sphingosine 1-Phosphate and Apolipoprotein M Levels and Their Correlations with Inflammatory Biomarkers in Patients with Untreated Familial Hypercholesterolemia
by: Lilla Juhász, et al.
Published: (2022-11-01) -
Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto’s thyroiditis on levothyroxine substitution
by: Sára Csiha, et al.
Published: (2023-05-01) -
LIPOPROTEIN(A) MEANING AS AN ADDITIONAL MARKER OF CARDIOVASCULAR RISK IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
by: V. A. Korneva, et al.
Published: (2016-06-01)